| |
|
|
|
Soleno Therapeutics Inc.  
|
|
1.82 -0.06 (-0.03%) |
08-23 16:00 |
|
Open: |
1.811 |
Pre close: |
1.88 |
Target:
|
2.78 
|
|
High: |
1.9 |
Low: |
1.81 |
Resistance:
|
2.38
2.80
|
|
Volume: |
19,381 |
Market Cap: |
58M |
Support:
|
1.70
1.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.92
|
MACD |
MACD(12,26):
|
-0.16 |
|
MA(20): |
2.01 |
Signal(12,26,9): |
-0.17  |
|
MA(100): |
2.33 |
Stochastic Oscillator |
%K(14,3):
|
36.58 |
|
MA(250): |
2.07 |
%D(3): |
37.64 |
|
Average Volume(K) |
3-Month: |
7233
|
52-Week |
High:
|
5.07 |
|
10-Days: |
3117 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
37.04 |
Change(%): |
-15.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.726 |
Return on Equity (ttm) |
-127.7 |
Shares Out. (M) |
21.44 |
|
EPS Est. Current Year |
-1.350 |
Return on Assets (ttm) |
-32.3 |
Shares Float (M) |
7.79 |
|
EPS Est. Next Year |
-1.050 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.50 |
|
EPS Est. Next Quarter |
-0.250 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
61.27 |
|
Forward EPS |
-0.791 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
148 |
|
Book Value (p.s.) |
0.440 |
EBITDA (p.s.) |
-0.721 |
P/E |
-2.51 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.14 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.99 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.85 |
P/CF |
-2.79 |
|
|
|
|
|
|
